BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson’s disease

T Foltynie
February 2009
Journal of Neurology, Neurosurgery & Psychiatry;Feb2009, Vol. 80 Issue 2, p141
Academic Journal
BACKGROUND: Levodopa induced dyskinesias (LID) are a common problem which ultimately limit the effective treatment of patients with Parkinson’s disease (PD). There is accumulating evidence that LID develop due to abnormal synaptic plasticity, which is in turn influenced by the release of brain derived neurotrophic factor (BDNF). METHODS: The influence of a common functional polymorphism of the BDNF gene on the risk of developing dyskinesias in a large cohort of patients with PD (n = 315), who were independently and variably treated with levodopa and/or other dopaminergic treatments, was investigated. RESULTS: Patients with the met allele of BDNF, associated with lower activity dependent secretion of BDNF, were at significantly higher risk of developing dyskinesias earlier in the course of treatment with dopaminergic agents (hazard ratio for each additional met allele 2.12, p = 0.001), which persisted following adjustment for potential confounding variables. CONCLUSION: This functional polymorphism may help predict which individuals are most at risk of LID and is consistent with the known actions of BDNF on synaptic plasticity in the striatum.


Related Articles

  • Mitochondrial DNA polymorphisms and the risk of Parkinson’s disease in Taiwan. Chen, C. M.; Kuan, C. C.; Lee-Chen, G.-J.; Wu, Y. R. // Journal of Neural Transmission;Aug2007, Vol. 114 Issue 8, p1017 

    A critical role of mitochondrial dysfunction has been implicated in the pathogenesis of Parkinson’s disease (PD). The association of mitochondrial DNA (mtDNA) polymorphisms 9055G/A, 10398G/A and 13708G/A with PD has been controversial. In this study we analyzed whether these three genetic...

  • No genetic association of the Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease. Levecque, C.; Destée, A.; Mouroux, V.; Becquet, E.; Defebvre, L.; Amouyel, P.; Chartier-Harlin, M.-C. // Journal of Neural Transmission;Sep2001, Vol. 108 Issue 8/9, p979 

    Summary. Parkinson's disease (PD) is a neurodegenerative disorder for which genetic susceptibility has been documented in sporadic and familial cases. Recently, a polymorphism located in exon 3 at codon 18 (S18Y) of the Ubiquitin Carboxy-terminal Hydrolase-L1 (UCH-L1) gene has been associated...

  • Genetic causes of Parkinson’s disease:UCHL-1. Healy, Daniel; Abou-Sleiman, Patrick; Wood, Nicholas // Cell & Tissue Research;Oct2004, Vol. 318 Issue 1, p189 

    The ubiquitin proteasome system is an important cellular pathway that ubiquitinates damaged proteins and degrades them via the 26S proteasome. Abnormalities of this pathway can result in molecular protein aggregation and have been associated with Parkinson’s disease (PD). UCHL-1, an...

  • Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset. Plaitakis, Andreas; Latsoudis, Helen; Kanavouras, Konstantinos; Ritz, Beate; Bronstein, Jeff M.; Skoula, Irene; Mastorodemos, Vasileios; Papapetropoulos, Spyridon; Borompokas, Nikolas; Zaganas, Ioannis; Xiromerisiou, Georgia; Hadjigeorgiou, George M.; Spanaki, Cleanthe // European Journal of Human Genetics;Mar2010, Vol. 18 Issue 3, p336 

    Parkinson's disease (PD), a common neurodegenerative disorder characterized by progressive loss of dopaminergic neurons and their terminations in the basal ganglia, is thought to be related to genetic and environmental factors. Although the pathophysiology of PD neurodegeneration remains...

  • Association study of the G258S transferrin gene polymorphism and Parkinson's disease in the Spanish population. Ezquerra, Mario; Campdelacreu, Jaume; Muñoz, Esteban; Tolosa, Eduard // Journal of Neurology;Oct2005, Vol. 252 Issue 10, p1269 

    Discusses the association of G258S transferrin polymorphism to Parkinson's disease (PD). Analysis of the Hardy-Weinberg-Equilibrium od genotype frequencies for cases and controls; Differences in the G258S transferrin genotype or allele frequencies between PD and control groups; Increase of GG...

  • Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.  // BMC Neurology;2011, Vol. 11 Issue 1, p89 

    The article presents a study on genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease (PD) in a Japanese population. The study investigated the relationship of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), and dopamine receptor (DR)...

  • UCHL1 S18Y variant is a risk factor for Parkinson's disease in Japan. Yoshihiro Miyake; Keiko Tanaka; Wakaba Fukushima; Chikako Kiyohara; Satoshi Sasaki; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Hiroyuki Shimada; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai // BMC Neurology;2012, Vol. 12 Issue 1, p62 

    Background: A recent meta-analysis on the UCHL1 S18Y variant and Parkinson's disease (PD) showed a significant inverse association between the Y allele and PD; the individual studies included in that meta-analysis, however, have produced conflicting results. We examined the relationship between...

  • POLYMORPHISMS OF METHYLENETETRAHYDROFOLATE REDUCTASE GENE MTHFR AND THIOL COMPOUNDS LEVELS IN DIFFERENT STAGES EVOLUTION OF PARKINSON'S DISEASE. Florczak, J.; Dorszewska, J.; Kempisty, B.; Chojnacka, K.; Trzeciak, W. H.; Kozubski, W. // Folia Neuropathologica;2005, Vol. 43 Issue 3, p203 

    This article presents an abstract of the research paper "Polymorphisms of Methylenetetrahydrofolate Reductase Gene MTHFR and Thiol Compounds Levels in Different Stages Evolution of Parkinson's Disease," which was discussed in the 13th Conference of the Polish Association of Neuropathologist. The...

  • Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease. Clark, Joanne; Reddy, Sonika; Kangni Zheng; Betensky, Rebecca A.; Simon, David K. // BMC Medical Genetics;2011, Vol. 12 Issue 1, p69 

    Background: Peroxisome proliferator-activated receptor-g co-activator (PGC)-1α is a transcriptional co-activator of antioxidant genes and a master regulator of mitochondrial biogenesis. Parkinson's disease (PD) is associated with oxidative stress and mitochondrial dysfunction and recent work...


Read the Article


Sign out of this library

Other Topics